http://apiprod.etf.internal.com/private/fund/PBE/fundreport
PBE

PBE

PowerShares Dynamic Biotechnology & Genome Portfolio
B

62
  • Overview
  • Efficiency
  • Tradability
  • Fit

PBE Fund Description

The PowerShares Dynamic Biotechnology & Genome Portfolio ETF tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

PBE Factset Analytics Insight

As is evident from its name, PBE goes beyond the scope of pure biotech firms, which causes PBE to differ substantially from other biotech ETFs and our segment benchmark. Only about 1/2 of its holdings overlap those of our biotech benchmark. Moreover, far from a plain-vanilla approach, PBE's underlying index uses a multifactor system (fundamental and technical factors) to select stocks and a tiered equal-weighting system to construct its portfolio. The approach produces a unique portfolio of biotech and peripheral-industry companies. PBE is one of the least liquid biotech ETFs but, in a highly liquid segment, that still translates to penny-wide spreads and ample block liquidity. While PBE's sizeable fee generates a strong headwind to tracking, it generally recovers some of its expense and overall lags its index by less than its fee.

PBE MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of October 22, 2017 the PowerShares Dynamic Biotechnology & Genome Portfolio MSCI ESG Fund Quality Score is 3.99 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. PBE ranks in the 4th percentile within its peer group and in the 9th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

PBE Top 10 Countries

PBE Top 10 Sectors

PBE Top 10 Holdings View All

PBE Summary Data

PowerShares
06/23/05
Open-Ended Fund
0.58%
$249.97M
$1.23M
0.2%

PBE Portfolio Data

$27.62B
-279.18
4.82
0.8%
12/18/17
30

PBE Index Data

Dynamic Biotechnology & Genome Intellidex Index
Tiered
Multi-Factor
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to PBE

N/A
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

PBE Portfolio Management

0.58%
0.4%
0.57%
0.06%

PBE Tax Exposures

20% / 39.6%
--
Qualified dividends
No

PBE Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:54:3648.57100
10:30:3748.46100
10:30:3748.46100
10:30:3748.46100
------
------
------
------
------
------
Bats BZX Real-time Quote - 17:12:50
Daily Spread
Premium/Discount
Volume

PBE Factset Analytics Block Liquidity

As of 10/23/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PBE. PBE is rated a 4 out of 5.

PBE Tradability

25,175
$1.23M
12,649
$578.89K
0.2%
$0.1
-0.05%
0.49% / -0.4%
None
100%
50,000
0.25
0.02%
0.47%
--
$48.74
4

PBE Geographic Exposure

PBESegment Benchmark
99.73% 100.00%
0.27% --

PBESegment Benchmark
99.73% 100.00%
0.27% --
99.73% / 0.27% 100.00% / 0.00%

PBE Performance Statistics

0.84
1.09
1.08
1.08
0.56%
Thomson Reuters US Biotechnology & Medical Research

PBE MSCI ESG Ratings

3.99 / 10
3.53
9.04
2.39%
20.23%
21.94

PBE BENCHMARK COMPARISON

    PBE
    30 Holdings
    Segment Benchmark
    120 Constituents
    Shared Holdings
    20 (Count)
     
    23.40% (Weight)
PBESegment Benchmark
73.37% 35.21%
16.95% 15.81%
8.63% 48.99%
1.05% 0.00%
45.81 -279.18
0.90% 0.27%
-- Medium